269 related articles for article (PubMed ID: 6190578)
1. The relationship between immunization and circulating antigen-specific plaque-forming cells.
Falkoff RJ; Zhu LP; Fauci AS
Cell Immunol; 1983 Jun; 78(2):392-9. PubMed ID: 6190578
[TBL] [Abstract][Full Text] [Related]
2. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.
Kehrl JH; Fauci AS
J Clin Invest; 1983 Apr; 71(4):1032-40. PubMed ID: 6339558
[TBL] [Abstract][Full Text] [Related]
3. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
Geha RS
J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
[TBL] [Abstract][Full Text] [Related]
4. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man.
Tarkowski A; Czerkinsky C; Nilsson LA
Clin Exp Immunol; 1985 Aug; 61(2):379-87. PubMed ID: 2412746
[TBL] [Abstract][Full Text] [Related]
6. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
Dziarski R
J Immunol; 1984 Nov; 133(5):2537-44. PubMed ID: 6207235
[TBL] [Abstract][Full Text] [Related]
7. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
Geha RS
J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal activation of canine B lymphocytes evaluated by a protein A reverse hemolytic plaque assay.
Felsburg PJ; Serra DA; Mandato VN; Jezyk PF
Vet Immunol Immunopathol; 1984 Jul; 6(3-4):353-64. PubMed ID: 6385465
[TBL] [Abstract][Full Text] [Related]
9. A hemolytic plaque assay for the detection of direct and indirect antibody-forming cells to keyhole limpet hemocyanin.
Herscowitz HB; Diblasio RC; Rosenberg JB
J Immunol Methods; 1975 Feb; 6(4):331-46. PubMed ID: 47369
[TBL] [Abstract][Full Text] [Related]
10. Antigen-secreting cells: enumeration of immunoglobulin-allotype-secreting cells in nonimmunized rabbits by means of hybrid-antibody-coated erythrocytes in a reverse hemolytic plaque assay.
Molinaro GA; Maron E; Dray S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1229-33. PubMed ID: 4133847
[TBL] [Abstract][Full Text] [Related]
11. Selective suppression by auto-anti-idiotypic antibody of B-cell idiotype repertoires generated after stimulation with the same hapten on T-dependent and T-independent carriers.
Szewczuk MR
Cell Immunol; 1983 Dec; 82(2):282-91. PubMed ID: 6360382
[TBL] [Abstract][Full Text] [Related]
12. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.
Burns EA; Lum LG; L'Hommedieu G; Goodwin JS
J Gerontol; 1993 Nov; 48(6):B231-6. PubMed ID: 8227990
[TBL] [Abstract][Full Text] [Related]
13. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
Ershler WB; Moore AL; Hacker MP
Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
[TBL] [Abstract][Full Text] [Related]
14. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
Geha RS
J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
[TBL] [Abstract][Full Text] [Related]
15. Regulation of anti-hapten antibody responses in vivo: memory, carrier-specific Lyt-2+ T cells can terminate antibody production without altering the peak of response.
Kanellopoulos-Langevin C; Mathieson BJ; Perkins A; Maynard A; Asofsky R
J Immunol; 1984 Apr; 132(4):1639-46. PubMed ID: 6199405
[TBL] [Abstract][Full Text] [Related]
16. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
Kodo H; Gale RP; Saxon A
J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
[TBL] [Abstract][Full Text] [Related]
17. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
Jin NR; Lum LG
Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
[TBL] [Abstract][Full Text] [Related]
18. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
Jirillo E; Kiyono H; Michalek SM; McGhee JR
J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
[TBL] [Abstract][Full Text] [Related]
19. Antigen-induced plaque-forming cell responses in cultures of peripheral blood mononuclear cells of human neonates and infants.
van Tol MJ; Zijlstra J; Zegers BJ; Ballieux RE
J Pediatr; 1984 Nov; 105(5):738-44. PubMed ID: 6389806
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line.
Friedman SM; Principato MA; Thompson GS; Teichman F
J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]